CD8A and neoplasm: When quantified as percentage of all immune cells, there were significant decreases of CD8+ T cells, NK cells, B cells and tumor-associated macrophages (TAMs), yet there was a dramatic increase from ~1% to ~50% of CD11b+ Gr1+ myeloid cells (Fig. 3b, c, and Supplementary Fig. 3).